As of June 2024 Ironwood Pharmaceuticals has a market cap of $1.00 Billion. This makes Ironwood Pharmaceuticals the world's 5176th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.00 B | -43.93% |
2023 | $1.78 B | -6.02% |
2022 | $1.90 B | -0.4% |
2021 | $1.90 B | 4.64% |
2020 | $1.82 B | -13.03% |
2019 | $2.09 B | 31.07% |
2018 | $1.59 B | -21.18% |
2017 | $2.02 B | 1.2% |
2016 | $2.00 B | 35.85% |
2015 | $1.47 B | -22.86% |
2014 | $1.91 B | 60.34% |
2013 | $1.19 B | 37.66% |
2012 | $0.86 B | 20.98% |
2011 | $0.71 B | 43.66% |
2010 | $0.49 B |
On Jun 1st, 2024 the market cap of Ironwood Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
AstraZeneca AZN | $241.89 B | 24,055.35% | ๐ฌ๐ง UK |
Nektar Therapeutics
NKTR | $0.23 B | -76.66% | ๐บ๐ธ USA |